Incannex Healthcare (IXHL) Profit After Tax (2022 - 2026)
Incannex Healthcare (IXHL) posted quarterly Profit After Tax of -$4.4 million for Q1 2026, down 7.27% year-on-year from -$4.7 million in Q1 2025, and up 33.28% on a QoQ basis from -$6.5 million in Q4 2025.
Incannex Healthcare (IXHL) Profit After Tax (2022 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Profit After Tax for 5 consecutive years, with -$4.4 million the latest figure, recorded in Q1 2026.
- Quarterly Profit After Tax fell 7.27% year-over-year to -$4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.7 million (down 126.55% YoY) and the FY2025 annual result came in at -$46.9 million, down 152.94% from the prior year.
- Profit After Tax grew to -$4.4 million in Q1 2026 per IXHL's latest filing, from -$6.5 million in the prior quarter.
- Over the last five years, Profit After Tax for IXHL reached as high as -$1.2 million in Q3 2023 and fell as low as -$31.4 million in Q2 2025.
- A 5-year average of -$7.0 million and a median of -$5.7 million in 2024 frame the typical range for Profit After Tax.
- The largest YoY upside for Profit After Tax was 40.8% in 2025 against a maximum downside of 412.47% in 2025.
- Year by year, Profit After Tax stood at -$2.9 million in 2022, then tumbled by 79.61% to -$5.2 million in 2023, then declined by 12.46% to -$5.9 million in 2024, then retreated by 10.64% to -$6.5 million in 2025, then soared by 33.28% to -$4.4 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$4.4 million, -$6.5 million, and -$6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | -4.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.35 Mn |
| Dec 31, 2025 | -6.52 Mn |
| Sep 30, 2025 | -6.41 Mn |
| Jun 30, 2025 | -31.44 Mn |
| Mar 31, 2025 | -4.06 Mn |
| Dec 31, 2024 | -5.89 Mn |
| Sep 30, 2024 | -5.42 Mn |
| Jun 30, 2024 | -6.14 Mn |
| Mar 31, 2024 | -6.85 Mn |
| Dec 31, 2023 | -5.24 Mn |
| Sep 30, 2023 | -1.24 Mn |
| Jun 30, 2023 | -7.75 Mn |
| Mar 31, 2023 | -3.77 Mn |
| Dec 31, 2022 | -2.92 Mn |